Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | CARDIAC REHABILITATION, OUTPATIENT (EFFECTIVE 09/01/2026) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BREAST ELASTOGRAPHY - ULTRASOUND OR MAGNETIC RESONANCE - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | FECAL MICROBIOTA TRANSPLANTATION (FECAL BACTERIOTHERAPY) - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BALLOON DILATION OF THE EUSTACHIAN TUBE (BDET) - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SPEECH AND LANGUAGE PATHOLOGY SWALLOWING REHABILITATION - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SCINTIMAMMOGRAPHY AND GAMMA IMAGING OF THE BREAST AND AXILLA - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | COBLATION, RADIOFREQUENCY ABLATION FOR MUSCULOSKELETAL CONDITIONS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TREATMENT OF VARICOSE VEINS/VENOUS INSUFFICIENCY - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | LUMBAR TRACTION DEVICES FOR THE TREATMENT OF LOW BACK PAIN | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR CYTOCHROME P450 POLYMORPHISMS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AIM MEDICAL POLICY - PEPAXTO ( Retired as of 12/9/2022 MLackley) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENETIC TESTING FOR SPECIFIED CONDITIONS USING TESTING PANELS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AUTOGRAFTS AND ALLOGRAFTS IN THE TREATMENT OF FOCAL ARTICULAR CARTILAGE LESIONS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | WIRELESS CAPSULE ENDOSCOPY FOR GASTROINTESTINAL DISORDERS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ONCOPROTEIN DES-GAMMA-CARBOXY PROTHROMBIN (DCP) IMMUNOASSAY | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AIM MEDICAL POLICY - KYPROLIS (CARFILZOMIB) (retired as of 10/06/2022) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SELF ADMINISTERED DRUGS (retired as of 10/7/2021) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TOTAL ARTIFICIAL HEARTS AND IMPLANTABLE VENTRICULAR ASSIST DEVICES | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | J0693 FETROJA (CEFIDEROCOL) - (RETIRED AS OF 02/02/2023) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AMBULATORY BLOOD PRESSURE MONITORING FOR SCREENING AND DIAGNOSIS OF HYPERTENSION | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | HEADACHES-NERVE BLOCKS/GANGLION BLOCKS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PALFORZIA (PEANUT (ARACHIS HUYPOGAEA) ALLERGEN POWDER-DNFP) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | IMPLANTABLE BONE-CONDUCTION AND BONE-ANCHORED HEARING DEVICES | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | OPTICAL COHERENCE TOMOGRAPHY OF THE BREAST AND/OR AXILLARY LYMPH NODES | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BMT - HEMATOPOIETIC CELL TRANSPLANTATION FOR ACUTE LYMPHOBLASTIC LEUKEMIA | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTRAVITREAL CORTICOSTEROID IMPLANTS FOR POSTERIOR NON-INFECTIOUS UVEITIS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | FECAL MICROBIOTA TRANSPLANTATION (FECAL BACTERIOTHERAPY, FECAL TRANSPLANT) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | IMMUNE GLOBULIN REPLACEMENT THERAPY MEDICATION USE GUIDELINES | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MAGNETIC RESONANCE ANGIOGRAPHY AND MAGNETIC RESONANCE VENOGRAPHY(EXAMPLE) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TELEMONITORING- REMOTE PATIENT MONITORING AND REMOTE THERAPEUTIC MONITORING | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BMT - HEMATOPOIETIC CELL TRANSPLANTATION FOR SOLID TUMORS OF CHILDHOOD | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | PROPRIETARY LABORATORY ANALYSES (PLA) CODES - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MATERNAL SERUM BIOMARKERS FOR PREDICTION OF ADVERSE OBSTETRIC OUTCOMES | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | HOME MONITORING DEVICE FOR AGE-RELATED MACULAR DEGENERATION | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | INTRAOCULAR RADIATION THERAPY FOR AGE-RELATED MACULAR DEGENERATION | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BALLOON OSTIAL DILATION FOR TREATMENT OF CHRONIC AND RECURRENT RHINOSINUSITIS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AIM MEDICAL POLICY - BENDAMUSTINE PRODUCTS (RETIRED AS OF 02/02/2023) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | COMPUTER-ASSISTED MUSCULOSKELETAL SURGICAL NAVIGATIONAL ORTHOPEDIC PROCEDURE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | POSITRON EMISSION TOMOGRAPHY (PET) SCANS FOR CARDIAC APPLICATIONS | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | TRIPTORELIN: TRIPTODUR (J3315) retired as of 10/8/2020 | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | NONTRADITIONAL BIOMARKERS IN RISK ASSESSMENT AND MANAGEMENT OF CARDIOVASCULAR DISEASE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | DIGITAL HEALTH TECHNOLOGIES FOR ATTENTION DEFICIT/HYPERACTIVITY DISORDER | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | AMBULATORY EVENT MONITORS AND MOBILE CARDIAC OUTPATIENT TELEMETRY | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SERUM MARKERS FOR THE DIAGNOSIS AND CARE OF INFLAMMATORY BOWEL DISEASE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | BCN ONLY - IMMEDIATE REPAIR OF TRAUMA TO NATURAL TEETH | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | ERAVACYCLINE: XERAVA (no code) RETIRED AS OF 10/8/2020 | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | SERUM BIOMARKER HUMAN EPIDIDYMIS PROTEIN 4 (HE4) | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | POLYMETABOLITE URINE TESTING FOR ADENOMATOUS POLYPS - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | GENE EXPRESSION PROFILING FOR CUTANEOUS MELANOMA - MEDICARE ADVANTAGE | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of Michigan and Blue Care Network | MISCELLANEOUS AND GENETIC AND MOLECULAR DIAGNOSTIC TESTS - MEDICARE ADVANTAGE | New policy |